T. Metsvaht, G. Nellis, H. Varendi, A. Nunn, S. Graham et al., High variability in the dosing of commonly used antibiotics revealed by a Europe-wide point prevalence study: implications for research and dissemination, BMC Pediatrics, vol.119, issue.6, p.41, 2015.
DOI : 10.1161/CIRCULATIONAHA.108.798751

G. Kearns and R. Young, Pharmacokinetics of cefotaxime and desacetylcefotaxime in the young, Diagnostic Microbiology and Infectious Disease, vol.22, issue.1-2, pp.97-1040732, 1995.
DOI : 10.1016/0732-8893(95)00052-C

C. Hornik, P. Fort, R. Clark, K. Watt, D. Benjamin et al., Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units, Early Human Development, vol.88, issue.2, pp.69-74, 2012.
DOI : 10.1016/S0378-3782(12)70019-1

S. Leroux, W. Zhao, P. Bétrémieux, P. Pladys, E. Saliba et al., Therapeutic guidelines for prescribing antibiotics in neonates should be evidence-based: a French national survey, Archives of Disease in Childhood, vol.161, issue.4, pp.394-398, 2015.
DOI : 10.1001/archpedi.161.5.446

URL : https://hal.archives-ouvertes.fr/hal-01147039

G. Pacifici, Pharmacokinetics of cephalosporins in the neonate: a review, Clinics, vol.66, issue.7, pp.1267-1274, 2011.
DOI : 10.1590/S1807-59322011000700024

W. Zhao, S. Leroux, and E. Jacqz-aigrain, Dosage individualization in children: integration of pharmacometrics in clinical practice, World Journal of Pediatrics, vol.75, issue.3, pp.197-203, 2014.
DOI : 10.1111/j.1365-2125.2012.04406.x

S. Leroux, M. Turner, C. Barin-le-guellec, H. Hill, J. Van-den-anker et al., Pharmacokinetic studies in Cefotaxime Dosing Optimization in Neonates, 2015.

, Antimicrobial Agents and Chemotherapy neonates: the utility of an opportunistic sampling design, Clin Pharmacokinet, vol.54, pp.1273-1285

W. Engle, American Academy of Pediatrics Committee on Fetus and Newborn Age terminology during the perinatal period, Pediatrics, vol.114, pp.1362-1364, 1915.

J. Mandema, D. Verotta, and L. Sheiner, Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects, Journal of Pharmacokinetics and Biopharmaceutics, vol.19, issue.5, pp.511-528, 1992.
DOI : 10.1007/978-1-4612-6333-3

J. Parke and B. Charles, Factors affecting oral cyclosporin disposition after heart transplantation: bootstrap validation of a population pharmacokinetic model, European Journal of Clinical Pharmacology, vol.56, issue.6-7, pp.481-487, 2000.
DOI : 10.1007/s002280000164

E. Comets, K. Brendel, and F. Mentré, Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: The npde add-on package for R, Computer Methods and Programs in Biomedicine, vol.90, issue.2, pp.154-166, 2008.
DOI : 10.1016/j.cmpb.2007.12.002

URL : https://hal.archives-ouvertes.fr/inserm-00274332

M. Jacobs, Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters, Clinical Microbiology and Infection, vol.7, issue.11, pp.589-596, 2001.
DOI : 10.1046/j.1198-743x.2001.00295.x

C. Stockmann, M. Spigarelli, S. Campbell, J. Constance, J. Courter et al., Considerations in the Pharmacologic Treatment and Prevention of Neonatal Sepsis, Pediatric Drugs, vol.31, issue.6, pp.67-81, 2014.
DOI : 10.1097/INF.0b013e31824acc33

J. Wynn and O. Levy, Role of Innate Host Defenses in Susceptibility to Early-Onset Neonatal Sepsis, Clinics in Perinatology, vol.37, issue.2, pp.307-337, 2010.
DOI : 10.1016/j.clp.2010.04.001

J. Wynn, T. Cornell, H. Wong, T. Shanley, and D. Wheeler, The Host Response to Sepsis and Developmental Impact, PEDIATRICS, vol.125, issue.5, pp.1031-1041, 2010.
DOI : 10.1542/peds.2009-3301

, Breakpoint tables for interpretation of MICs and zone diameters, European Committee on Antimicrobial Susceptibility Testing, 2016.

M. Sharland, Manual of childhood infections. The Blue Book, 2011.

, Thomson Reuters Clinical Editorial Staff. 2011. NeoFax. PDR Network

N. Holford, A Size Standard for Pharmacokinetics, Clinical Pharmacokinetics, vol.30, issue.5, pp.329-332, 1996.
DOI : 10.2165/00003088-199630050-00001

G. Kearns, R. Jacobs, B. Thomas, T. Darville, and J. Trang, Cefotaxime and desacetylcefotaxime pharmacokinetics in very low birth weight neonates, The Journal of Pediatrics, vol.114, issue.3, pp.461-467, 1989.
DOI : 10.1016/S0022-3476(89)80573-6

R. Jacobs and G. Kearns, Cefotaxime and desacetylcefotaxime in neonates and children: A review of microbiologic, pharmacokinetic, and clinical experience, Diagnostic Microbiology and Infectious Disease, vol.12, issue.1, pp.93-990732, 1989.
DOI : 10.1016/0732-8893(89)90052-7

J. Baird-lambert, P. Doyle, D. Thomas, M. Cvejic, and N. Buchanan, Pharmacokinetics of cefotaxime in neonates, Journal of Antimicrobial Chemotherapy, vol.13, issue.5, pp.471-477, 1984.
DOI : 10.1093/jac/13.5.471

URL : https://academic.oup.com/jac/article-pdf/13/5/471/2299798/13-5-471.pdf

G. Mccracken, N. Threlkeld, and M. Thomas, Pharmacokinetics of cefotaxime in newborn infants., Antimicrobial Agents and Chemotherapy, vol.21, issue.4, pp.683-684, 1982.
DOI : 10.1128/AAC.21.4.683

Y. Aujard, F. Brion, E. Jacqz-aigrain, M. Kasse, P. Chretien et al., Pharmacokinetics of cefotaxime and desacetylcefotaxime in the newborn, Diagnostic Microbiology and Infectious Disease, vol.12, issue.1, pp.87-910732, 1989.
DOI : 10.1016/0732-8893(89)90051-5

D. Kafetzis, D. Brater, A. Kapiki, C. Papas, H. Dellagrammaticas et al., Treatment of severe neonatal infections with cefotaxime . Efficacy and pharmacokinetics, J Pediatr, vol.100, pp.483-489, 1982.

J. Crooks, L. White, L. Burville, B. Speidel, and D. Reeves, Pharmacokinetics of cefotaxime and desacetyl-cefotaxime in neonates, Journal of Antimicrobial Chemotherapy, vol.14, issue.suppl B, pp.97-101, 1984.
DOI : 10.1093/jac/14.suppl_B.97

J. De-louvois, A. Mulhall, and R. Hurley, The safety and pharmacokinetics of cefotaxime in the treatment of neonates, Pediatr Pharmacol, vol.2, pp.275-284, 1982.

J. Gouyon, A. Pechinot, C. Safran, P. Chretien, D. Sandre et al., Pharmacokinetics of cefotaxime in preterm infants, Dev Pharmacol Ther, vol.14, pp.29-34, 1990.

M. Ahsman, E. Wildschut, D. Tibboel, and R. Mathot, Pharmacokinetics of Cefotaxime and Desacetylcefotaxime in Infants during Extracorporeal Membrane Oxygenation, Antimicrobial Agents and Chemotherapy, vol.54, issue.5, pp.1734-1741, 2010.
DOI : 10.1128/AAC.01696-09

URL : http://aac.asm.org/content/54/5/1734.full.pdf

M. Tod, V. Jullien, and G. Pons, Facilitation of Drug Evaluation in Children by??Population Methods and Modelling???, Clinical Pharmacokinetics, vol.116, issue.4, pp.231-243, 2008.
DOI : 10.1208/ps020103

A. European-medicines, Guideline on the investigation of medicinal products in the term and preterm neonate, 2009.

M. Rhodin, B. Anderson, A. Peters, M. Coulthard, B. Wilkins et al., Human renal function maturation: a quantitative description using weight and postmenstrual age, Pediatric Nephrology, vol.17, issue.1, pp.67-76, 2009.
DOI : 10.1001/archinte.1916.00080130010002

C. Abitbol, M. Defreitas, and J. Strauss, Assessment of kidney function in preterm infants: lifelong implications, Pediatric Nephrology, vol.29, issue.12, 2016.
DOI : 10.1007/s00467-014-2793-8

W. Zhao, F. Kaguelidou, V. Biran, D. Zhang, K. Allegaert et al., External evaluation of population pharmacokinetic models of vancomycin in neonates: the transferability of published models to different clinical settings, British Journal of Clinical Pharmacology, vol.49, issue.4, pp.1068-1080, 2013.
DOI : 10.5414/CPP49247

S. Yee, A. Nguyen, C. Brown, R. Savic, Y. Zhang et al., Reduced Renal Clearance of Cefotaxime in Asians with a Low-Frequency Polymorphism of OAT3 (SLC22A8), Journal of Pharmaceutical Sciences, vol.102, issue.9, pp.3451-3457, 2013.
DOI : 10.1002/jps.23581

C. Barker, E. Germovsek, R. Hoare, J. Lestner, J. Lewis et al., Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology, Advanced Drug Delivery Reviews, vol.73, pp.127-139, 2014.
DOI : 10.1016/j.addr.2014.01.002

URL : https://doi.org/10.1016/j.addr.2014.01.002

W. Zhao, H. Hill, L. Guellec, C. Neal, T. Mahoney et al., ABSTRACT, Antimicrobial Agents and Chemotherapy, vol.58, issue.11, pp.6572-658003568, 2014.
DOI : 10.1128/AAC.03568-14

URL : https://hal.archives-ouvertes.fr/hal-00218335

M. Levison and J. Levison, Pharmacokinetics and Pharmacodynamics of Antibacterial Agents, Infectious Disease Clinics of North America, vol.23, issue.4, pp.791-815, 2009.
DOI : 10.1016/j.idc.2009.06.008

W. Craig, Does the Dose Matter?, Clinical Infectious Diseases, vol.43, issue.s3, pp.233-237, 2001.
DOI : 10.1001/archinte.149.10.2269

A. Macgowan, Elements of design: the knowledge on which we build, Clinical Microbiology and Infection, vol.10, pp.6-11, 2004.
DOI : 10.1111/j.1470-9465.2004.00863.x

W. Craig, Basic pharmacodynamics of antibacterials with clinical applications to the use of ??-lactams, glycopeptides, and linezolid, Infectious Disease Clinics of North America, vol.17, issue.3, pp.479-501, 2003.
DOI : 10.1016/S0891-5520(03)00065-5

I. Lutsar and T. Metsvaht, Understanding pharmacokinetics/pharmacodynamics in managing neonatal sepsis, Current Opinion in Infectious Diseases, vol.23, issue.3, pp.201-207816, 2006.
DOI : 10.1097/QCO.0b013e328337bb42

R. Bertels, B. Semmekrot, G. Gerrits, and J. Mouton, Serum Concentrations of Cefotaxime and its Metabolite Desacetyl-cefotaxime in Infants and Children During Continuous Infusion, Infection, vol.14, issue.Suppl B, pp.415-420, 2008.
DOI : 10.1007/s15010-008-7274-1

J. Roberts, C. Stockmann, J. Constance, J. Stiers, M. Spigarelli et al., Pharmacokinetics and Pharmacodynamics of Antibacterials, Antifungals, and Antivirals Used Most Frequently in Neonates and Infants, Clinical Pharmacokinetics, vol.182, issue.6, pp.581-610, 2014.
DOI : 10.1086/317600

V. Fanos and A. Dall-'agnola, Antibiotics in Neonatal Infections, Drugs, vol.58, issue.3, pp.405-42700003495, 1999.
DOI : 10.2165/00003495-199958030-00003

F. Vallée and M. Lebel, Comparative study of pharmacokinetics and serum bactericidal activity of ceftizoxime and cefotaxime., Antimicrobial Agents and Chemotherapy, vol.35, issue.10, pp.2057-2064, 1991.
DOI : 10.1128/AAC.35.10.2057

C. Taketomo, J. Hodding, and D. Kraus, Pediatric and neonatal dosage handbook, pp.2014-2015